zhangjian huang
China Pharmaceutical University
Nanjing, China
Review Editor
Anti-Cancer Drugs
- Frontiers in Drug Discovery
- Anti-Cancer Drugs
- Editorial Board
Type at least 3 characters
122 editors
Shape the future of research in your field
Join the board
Editors
Review Editors
farhadul islam
University of Rajshahi
Rajshahi, Bangladesh
Review Editor
Anti-Cancer Drugs
sheng jiang
China Pharmaceutical University
Nanjing, China
Review Editor
Anti-Cancer Drugs
zhong-xing jiang
Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences (CAS)
Wuhan, China
Review Editor
Anti-Cancer Drugs
lucĂa jimĂ©nez
Sols-Morreale Biomedical Research Institute (IIBM), Faculty of Medicine, Autonomous University of Madrid
Madrid, Spain
Review Editor
Anti-Cancer Drugs
silvia jiménez-morales
Laboratorio de InnovaciĂłn y Medicina de PrecisiĂłn, NĂşcleo A, Instituto Nacional de Medicina GenĂłmica
Mexico, Mexico
Review Editor
Anti-Cancer Drugs
partha karmakar
Abzena (United Kingdom)
Cambridge, United Kingdom
Review Editor
Anti-Cancer Drugs
seong jong kim
USDA Agricultural Research Service
Oxford, United States
Review Editor
Anti-Cancer Drugs
dhiraj kumar
University of Texas MD Anderson Cancer Center
Houston, United States
Review Editor
Anti-Cancer Drugs
dr. prem prakash kushwaha
School of Medicine, Case Western Reserve University
Cleveland, United States
Review Editor
Anti-Cancer Drugs
chong li
Southwest University
Chongqing, China
Review Editor
Anti-Cancer Drugs
guo-bo li
Sichuan University
Chengdu, China
Review Editor
Anti-Cancer Drugs
shiliang li
East China University of Science and Technology
Shanghai, China
Review Editor
Anti-Cancer Drugs
zhengqiu li
Jinan University
Guangzhou, China
Review Editor
Anti-Cancer Drugs
wukun liu
Nanjing University of Chinese Medicine
Nanjing, China
Review Editor
Anti-Cancer Drugs
xin hua liu
Anhui Medical University
Hefei, China
Review Editor
Anti-Cancer Drugs